Rchr
J-GLOBAL ID：202401001399309559
Update date: Nov. 16, 2024
Ainai Akira
アイナイ アキラ | Ainai Akira
Affiliation and department：
Job title：
Chief
Papers (79)：
-
Daisuke Kawata, Hideyuki Iwai, Seiya Oba, Yoji Komiya, Ryuji Koike, Sho Miyamoto, Takayuki Kanno, Akira Ainai, Tadaki Suzuki, Tadashi Hosoya, et al. Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2. Cytokine. 2024. 178. 156592-156592
-
Midori Nakamura-Hoshi, Hiroshi Ishii, Takushi Nomura, Masako Nishizawa, Trang Thi Thu Hau, Nozomi Kuse, Midori Okazaki, Akira Ainai, Tadaki Suzuki, Hideki Hasegawa, et al. Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques. Molecular therapy : the journal of the American Society of Gene Therapy. 2024
-
Masashi Shingai, Sayaka Iida, Naoko Kawai, Mamiko Kawahara, Toshiki Sekiya, Marumi Ohno, Naoki Nomura, Chimuka Handabile, Tomomi Kawakita, Ryosuke Omori, et al. Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire. Journal of virology. 2024. 98. 3. e0199523
-
Eriko Morino, Sohtaro Mine, Noriko Tomita, Yukari Uemura, Yosuke Shimizu, Sho Saito, Tetsuya Suzuki, Nobumasa Okumura, Haruka Iwasaki, Junko Terada, et al. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults. NEJM evidence. 2024. 3. 3. EVIDoa2300290
-
Tomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto, Naoko Iwata-Yoshikawa, Naomi M Seki, Nozomi Shiwa-Sudo, Akira Ainai, Keiji Dohi, Eiji Nikaido, Akiko Mukai, et al. Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice. Scientific reports. 2024. 14. 1. 2599-2599
ｍore...
Return to Previous Page
